Dividends Calendar Earnings Calendar
OVID

OVID | Ovid Therapeutics Inc

Ovid Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 265.13M
  • Prev closed: 4.02
  • Open: 4.03
  • High: 4.14
  • Low: 3.97
  • 52 week low: 2.25
  • 52 week high: 9.4
  • Dividends:No Dividends

Next ER: August 16, 2021 



Top Stories (OVID)

    Company Profile

    Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company?s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing soticlestat in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 11, 2021
    August 16, 2021-0.23 / -0.164- / -
    May 13, 20212.53 / 1.45208.38M / 100.53MBeat!
    April 1, 2021- / -0.3099- / 4.16M
    March 15, 2021-0.34 / -0.30565.7M / 4.16MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 16, 2021 3.740 4.010
    4.050
    3.730
    363.39K -7.43%
    Aug 13, 2021 4.040 3.784
    4.200
    3.784
    522.16K 3.32%
    Aug 12, 2021 3.910 3.800
    3.910
    3.800
    190.05K 1.82%
    Aug 11, 2021 3.840 3.830
    3.870
    3.710
    275.26K 1.59%
    Aug 10, 2021 3.780 3.740
    3.790
    3.650
    312.48K 1.07%
    Aug 9, 2021 3.740 3.750
    3.830
    3.730
    236.12K 0.27%
    Aug 6, 2021 3.730 3.760
    3.760
    3.660
    187.11K -0.27%
    Aug 5, 2021 3.740 3.680
    3.750
    3.650
    187.79K 1.91%
    Aug 4, 2021 3.670 3.730
    3.790
    3.640
    241.64K -0.81%
    Aug 3, 2021 3.700 3.760
    3.810
    3.655
    374.10K -0.8%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:67

    News

    News for (OVID)

    This company doesn't provide a dividend.


    Talk about Ovid Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 16, 2021 (Same day)

    jobs.ch doyu cig sbs tme niu gern ovid aiv nat nvgs rmed 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 50
    HOLD 50
    SELL 0

    Their Official Profiles 

    TwitterLinkedInInstagramYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    How to Day Trade for a Living
    Buy on Amazon

    Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.

    A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology